Shares in Millipore and Molecular Devices were the two leading decliners in the BCW Index for the week ended Tuesday, falling 7.4 percent and 5.4 percent, respectively. Millipore’s shares fell after the firm’s investor analyst day, during which it acknowledged some difficulties with its Upstate unit. Agilent led gainers for the week with a 4.7-percent rise.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.